Comtan (entacapone) - Novartis, Orion Corp
A Study on the Efficacy and Safety of Entacapone in the Treatment of Pain in Parkinson's Disease (ChiCTR) - Oct 16, 2026 - P=N/A | N=100 | Not yet recruiting | Sponsor: West China Fourth Hospital of Sichuan University; West China Fourth Hospital of Sichuan University 
New trial • CNS Disorders • Movement Disorders • Pain • Parkinson's Disease
https://www.chictr.org.cn/showproj.html?proj=338905
 
Oct 16, 2026
 
Prev Next